FIELD: medicine.
SUBSTANCE: dermal flap is simulated in laboratory animals on the second day of experiment. L-norvalin is administered intragastrically in a daily dose of 10.0 mg/kg from the first experimental days every 46 hours.
EFFECT: higher dermal flap survival growth in reduced circulation due to the activation of the pre-conditioning process using the pharmacological preparation.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH RESVERATROL | 2012 |
|
RU2511061C1 |
METHOD FOR INCREASING SKIN GRAFT SURVIVAL IN REDUCED CIRCULATION ENVIRONMENT WITH USE OF DIHYDROQUERCETIN | 2014 |
|
RU2547786C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH MINOXIDIL | 2012 |
|
RU2497201C1 |
METHOD FOR PHARMACOLOGICAL STIMULATION OF PEDICLE SKIN FLAP SURVIVAL WITH NICORANDYL | 2012 |
|
RU2507598C1 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF SKELETAL MUSCLE ISCHEMIA WITH L-NORVALINE | 2012 |
|
RU2507596C1 |
METHOD FOR DERMAL FLAP SURVIVAL GROWTH IN REDUCED CIRCULATION WITH SILDENAFIL | 2012 |
|
RU2498414C1 |
METHOD FOR STIMULATING NEOANGIOGENESIS IN ISCHEMIC SKELETAL MUSCLE | 2014 |
|
RU2547692C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF SKELETAL MUSCLE WITH RESVERATROL | 2012 |
|
RU2518965C1 |
METHOD FOR IMPROVING SURVIVAL RATE OF ISCHEMIC TISSUES (ISOLATED SKIN PEDICLE FLAP) IN REDUCED BLOOD CIRCULATION | 2010 |
|
RU2429547C1 |
METHOD FOR STIMULATING EXCISED LIVER REGENERATION WITH L-NORVALINE | 2014 |
|
RU2556609C1 |
Authors
Dates
2014-04-20—Published
2012-12-27—Filed